Market Place
Sourcing Support
All News #Library
Biotech
Gradalis` Vigil Boosts Survival in cTMB-H/HRP Ovarian Cancer
14 Jan 2026 //
GLOBENEWSWIRE
Gradalis Appoints Steven D. Weinstein As Chief Executive Officer
12 Jan 2026 //
GLOBENEWSWIRE
Gradalis Develops Exome Sequencing Pipeline for Tumor Mutation
14 Mar 2025 //
GLOBENEWSWIRE
Gradalis Secures FDA RMAT for Vigil Immunotherapy in Ovarian Cancer
05 Feb 2025 //
GLOBENEWSWIRE
GRAD1405 bi-shRNAi Candidate First to Show Positive Impact on KRAS Mutations
04 Jan 2024 //
GLOBENEWSWIRE
Solve & Gradalis Sign Agreement to Develop a Novel Gene Therapy Targeting HIBM
31 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.